Most notably male breast cancer is diagnosed at older ages, presents at higher stage, has a bimodal age-frequency [4], [6], racial differences [6], distinct histological subtypes, immunophenotypic variations [4], [6], [7], low survival rates [4], and differential genetic mutations, such as CYP17 polymorphism [8], androgen receptor (AR) [9], and CHEK2 mutations [10]. This evidence concerns the gene AR and breast cancer.